| Accession Number | 0001193125-26-315240 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 24, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | American Depositary Shares | Derivative | Jul 22, 2026 | Sale | 1,367 | $50.07 | $68,445.69 | 1,369 | Indirect | F-Prime Capital Partners Life Sciences Advisors Fund VI LP | View Details | |
10% Owner | American Depositary Shares | Derivative | Jul 22, 2026 | Sale | 16,085 | $50.07 | $805,375.95 | 16,086 | Indirect | F-Prime Capital Partners Life Sciences Fund VI LP | View Details |